The prospect of using liquid biopsy in diagnosis and treatment strategy in patients with carcinomas of unknown primary

Background. The search and use of new molecular prognostic and predictive markers of efficacy detected by liquid biopsy are aimed at understanding the biology of Carcinomas of Unknown Primary (CUP) and improving results of patient treatment. The review is devoted to advances in scientific and clinic...

Full description

Bibliographic Details
Main Authors: I. B. Kononenko, M. G. Filippova, A. V. Snegovoy, S. L. Gutorov
Format: Article
Language:Russian
Published: ABV-press 2021-01-01
Series:Успехи молекулярной онкологии
Subjects:
Online Access:https://umo.abvpress.ru/jour/article/view/299
_version_ 1797702312223834112
author I. B. Kononenko
M. G. Filippova
A. V. Snegovoy
S. L. Gutorov
author_facet I. B. Kononenko
M. G. Filippova
A. V. Snegovoy
S. L. Gutorov
author_sort I. B. Kononenko
collection DOAJ
description Background. The search and use of new molecular prognostic and predictive markers of efficacy detected by liquid biopsy are aimed at understanding the biology of Carcinomas of Unknown Primary (CUP) and improving results of patient treatment. The review is devoted to advances in scientific and clinical research on this issue.Materials and methods. In order to assess the current state of the problem, a search and analysis of relevant data of the scientific databases PubMed, Medline, RISC was carried out.Results. The scientific rationale for the use of liquid biopsy in clinical practice to improve the treatment of cancer patients with CUP is presented. The results of the use of modern approaches to the analysis of fluid biopsy samples in CUP are presented. In particular, the features of using circulating free DNA, circulating tumor DNA, circulating tumor cells in the analysis are considered. The modern possibilities of determining tissue specificity using liquid biopsy in CUP are discussed. The prospects for the development of liquid biopsy for improving diagnostics, determining the prognosis of the disease, and choosing a strategy for treating CUP and the treatment monitoring have been determined.Conclusion. A review of the literature confirms that modern methods of molecular profiling of tumor cells obtained both as a result of liquid biopsy and tissue biopsies will make a significant contribution to the determination of tissue specificity, molecular characteristics of CUP for a personalized approach in order to improve strategies and treatment outcomes for patients with CUP.
first_indexed 2024-03-12T04:49:03Z
format Article
id doaj.art-a656229e38fb474a981360d63cf1cfe6
institution Directory Open Access Journal
issn 2313-805X
2413-3787
language Russian
last_indexed 2024-03-12T04:49:03Z
publishDate 2021-01-01
publisher ABV-press
record_format Article
series Успехи молекулярной онкологии
spelling doaj.art-a656229e38fb474a981360d63cf1cfe62023-09-03T09:26:36ZrusABV-pressУспехи молекулярной онкологии2313-805X2413-37872021-01-0174101910.17650/2313-805X-2020-7-4-10-19195The prospect of using liquid biopsy in diagnosis and treatment strategy in patients with carcinomas of unknown primaryI. B. Kononenko0M. G. Filippova1A. V. Snegovoy2S. L. Gutorov3ФГБУ «Национальный медицинский исследовательский центр онкологии им. Н. Н. Блохина» Минздрава РоссииФГБУ «Национальный медицинский исследовательский центр онкологии им. Н. Н. Блохина» Минздрава РоссииФГБУ «Национальный медицинский исследовательский центр онкологии им. Н. Н. Блохина» Минздрава РоссииФГБУ «Национальный медицинский исследовательский центр онкологии им. Н. Н. Блохина» Минздрава РоссииBackground. The search and use of new molecular prognostic and predictive markers of efficacy detected by liquid biopsy are aimed at understanding the biology of Carcinomas of Unknown Primary (CUP) and improving results of patient treatment. The review is devoted to advances in scientific and clinical research on this issue.Materials and methods. In order to assess the current state of the problem, a search and analysis of relevant data of the scientific databases PubMed, Medline, RISC was carried out.Results. The scientific rationale for the use of liquid biopsy in clinical practice to improve the treatment of cancer patients with CUP is presented. The results of the use of modern approaches to the analysis of fluid biopsy samples in CUP are presented. In particular, the features of using circulating free DNA, circulating tumor DNA, circulating tumor cells in the analysis are considered. The modern possibilities of determining tissue specificity using liquid biopsy in CUP are discussed. The prospects for the development of liquid biopsy for improving diagnostics, determining the prognosis of the disease, and choosing a strategy for treating CUP and the treatment monitoring have been determined.Conclusion. A review of the literature confirms that modern methods of molecular profiling of tumor cells obtained both as a result of liquid biopsy and tissue biopsies will make a significant contribution to the determination of tissue specificity, molecular characteristics of CUP for a personalized approach in order to improve strategies and treatment outcomes for patients with CUP.https://umo.abvpress.ru/jour/article/view/299опухоль невыявленной первичной локализациижидкостная биопсияциркулирующие опухолевые клеткимолекулярное профилированиеэкспрессия геновтаргетная терапия
spellingShingle I. B. Kononenko
M. G. Filippova
A. V. Snegovoy
S. L. Gutorov
The prospect of using liquid biopsy in diagnosis and treatment strategy in patients with carcinomas of unknown primary
Успехи молекулярной онкологии
опухоль невыявленной первичной локализации
жидкостная биопсия
циркулирующие опухолевые клетки
молекулярное профилирование
экспрессия генов
таргетная терапия
title The prospect of using liquid biopsy in diagnosis and treatment strategy in patients with carcinomas of unknown primary
title_full The prospect of using liquid biopsy in diagnosis and treatment strategy in patients with carcinomas of unknown primary
title_fullStr The prospect of using liquid biopsy in diagnosis and treatment strategy in patients with carcinomas of unknown primary
title_full_unstemmed The prospect of using liquid biopsy in diagnosis and treatment strategy in patients with carcinomas of unknown primary
title_short The prospect of using liquid biopsy in diagnosis and treatment strategy in patients with carcinomas of unknown primary
title_sort prospect of using liquid biopsy in diagnosis and treatment strategy in patients with carcinomas of unknown primary
topic опухоль невыявленной первичной локализации
жидкостная биопсия
циркулирующие опухолевые клетки
молекулярное профилирование
экспрессия генов
таргетная терапия
url https://umo.abvpress.ru/jour/article/view/299
work_keys_str_mv AT ibkononenko theprospectofusingliquidbiopsyindiagnosisandtreatmentstrategyinpatientswithcarcinomasofunknownprimary
AT mgfilippova theprospectofusingliquidbiopsyindiagnosisandtreatmentstrategyinpatientswithcarcinomasofunknownprimary
AT avsnegovoy theprospectofusingliquidbiopsyindiagnosisandtreatmentstrategyinpatientswithcarcinomasofunknownprimary
AT slgutorov theprospectofusingliquidbiopsyindiagnosisandtreatmentstrategyinpatientswithcarcinomasofunknownprimary
AT ibkononenko prospectofusingliquidbiopsyindiagnosisandtreatmentstrategyinpatientswithcarcinomasofunknownprimary
AT mgfilippova prospectofusingliquidbiopsyindiagnosisandtreatmentstrategyinpatientswithcarcinomasofunknownprimary
AT avsnegovoy prospectofusingliquidbiopsyindiagnosisandtreatmentstrategyinpatientswithcarcinomasofunknownprimary
AT slgutorov prospectofusingliquidbiopsyindiagnosisandtreatmentstrategyinpatientswithcarcinomasofunknownprimary